School of Pharmacy and Pharmaceutical Sciences> </td> <td valign=

      Center of Excellence in Pharmacokinetics and Pharmacodynamics
   
  CEPKPD Home
  Mission
  Advisory Committee
  Faculty
  Staff & Students
  Symposia & Seminars
  Facilities
  Useful Links
  Support
   
   


DR. ALAN FORREST

DR. ALAN FORREST
      Dr. Forrest is a Clinical Associate Professor of Pharmacy and Adjunct Associate Professor of Pharmaceutical Sciences. He received his PharmD from the University of Southern California (1979). He is currently Director (Pharmacometric and Biostatistical Analysis) of the SUNYAB Clinical Pharmacokinetics Laboratory at Millard Fillmore Hospital. His PK/PD modeling interests and capabilities include novel models and methods for 'individual' and 'population' PK/PD system analysis; 'all' drug classes studied, with an emphasis on anti-infective and anti-cancer drugs, the development of optimally informative and efficient PK/PD study designs, clinical and research applications of adaptive feedback control to the optimization of drug therapy, and Translational PK/PD research, integrating, linking and bridging in vitro, animal, and human study systems.

Email: forrest@buffalo.edu

Selected Publications

1. Sher HI, Jodrell DI, Iversen JM, Curley T, Tong W, Egorin MJ, Forrest A: Use of Adaptive Control with Feedback to Individualize Suramin Dosing. Cancer Research, 52 (1):64-70, 1992.

2. Dodian PF, de Valeriola D, Crespigne N, Kantrowitz JD, Piccart M, Wery F, Kerger J, Egorin MJ, Forrest A, Bachur NR, Alaerts P, Carver A, Rastogi, R, Saletan S: Phase I Clinical and Pharmacokinetic Study of Zeniplatin, a New Platinum Complex. Annals of Oncology 2(8):589-596, 1991.

3. Weidle, PJ, Skiest, DJ, Forrest A: Multiple-dose Activated Charcoal as Adjunctive Therapy after a Chronic Phenytoin Intoxication. Clinical Pharmacy 10(9):711-714, 1991.

4. de Valeriola DL, Ross DD, Forrest A, Cuddy DP, Egorin MJ: Use of Plasma Cytotoxic Activity to Model Cytotoxic Pharmacodynamics of Anticancer Drugs. Cancer Chemotherapy and Pharmacology 29(2):133-140, 1991.